tomeko

3-Methylglutaconic aciduria type 3

Just diagnosed with 3-Methylglutaconic aciduria type 3?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees 3-Methylglutaconic aciduria type 3, look for clinical trials, and connect with others living with it — all in one place.

Open the full 3-Methylglutaconic aciduria type 3 hub →

Overview

3-Methylglutaconic aciduria type 3 is a rare condition. Also known as Autosomal recessive optic atrophy plus syndrome, Autosomal recessive optic atrophy type 3, Costeff optic atrophy syndrome, Costeff syndrome, Infantile optic atrophy with chorea and spastic paraplegia, MGA3. Tomeko brings together the specialists, research, clinical trials, treatments and community for 3-Methylglutaconic aciduria type 3 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:67047 · OMIM 258501 · ICD-10 E71.1 · GARD 0005663

Find care for 3-Methylglutaconic aciduria type 3

Authoritative references for 3-Methylglutaconic aciduria type 3

Common questions

I was just diagnosed with 3-Methylglutaconic aciduria type 3 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees 3-Methylglutaconic aciduria type 3, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for 3-Methylglutaconic aciduria type 3?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat 3-Methylglutaconic aciduria type 3, filtered to your area.

Are there clinical trials for 3-Methylglutaconic aciduria type 3?

Tomeko shows live, recruiting studies for 3-Methylglutaconic aciduria type 3 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com